The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.

Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther (2012) 6.92

Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc (2013) 1.80

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol (2014) 1.58

Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs. Mayo Clin Proc (2015) 1.51

Electronic health record design and implementation for pharmacogenomics: a local perspective. Genet Med (2013) 1.48

Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet (2012) 1.41

Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project". Am J Med Genet C Semin Med Genet (2014) 1.30

Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties. Pharmgenomics Pers Med (2014) 1.26

Pharmacogenetics in clinical practice: how far have we come and where are we going? Pharmacogenomics (2013) 1.15

Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans. Pharmacogenomics J (2013) 1.14

Ethical, legal, and social implications of incorporating genomic information into electronic health records. Genet Med (2013) 1.11

Pharmacogenetics and cardiovascular disease--implications for personalized medicine. Pharmacol Rev (2013) 1.04

Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice. ISRN Pharmacol (2013) 0.98

Implementation and utilization of genetic testing in personalized medicine. Pharmgenomics Pers Med (2014) 0.97

Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy (2014) 0.96

Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. J Natl Cancer Inst (2014) 0.94

Pharmacogenomics of chemotherapeutic susceptibility and toxicity. Genome Med (2012) 0.89

CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics? Pharmacotherapy (2014) 0.88

Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenet Genomics (2014) 0.87

Establishment of CYP2D6 reference samples by multiple validated genotyping platforms. Pharmacogenomics J (2014) 0.86

Systems biology approaches to adverse drug effects: the example of cardio-oncology. Nat Rev Clin Oncol (2015) 0.85

Surveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal Genomics. Yearb Med Inform (2014) 0.83

Integrating pharmacogenomics into electronic health records with clinical decision support. Am J Health Syst Pharm (2016) 0.79

Using systems approaches to address challenges for clinical implementation of pharmacogenomics. Wiley Interdiscip Rev Syst Biol Med (2013) 0.79

Implications of the incidentalome for clinical pharmacogenomics. Pharmacogenomics (2013) 0.78

Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science. Pharmacogenomics (2013) 0.77

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges. Clin Transl Sci (2016) 0.77

Iterative Development and Evaluation of a Pharmacogenomic-Guided Clinical Decision Support System for Warfarin Dosing. Appl Clin Inform (2016) 0.75

Novel Disease-Drug Database Demonstrating Applicability for Pharmacogenomic-Based Prescribing. Clin Pharmacol Ther (2016) 0.75

A brighter future for the implementation of pharmacogenomic testing. Eur J Hum Genet (2016) 0.75

Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events. J Clin Endocrinol Metab (2016) 0.75

Use of contemporary genetics in cardiovascular diagnosis. Circulation (2014) 0.75

Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice? Curr Opin Cardiol (2013) 0.75

"The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems". Clin Pharmacol Ther (2017) 0.75

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther (2017) 0.75

Exploring public genomics data for population pharmacogenomics. PLoS One (2017) 0.75

Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Pharmacogenet Genomics (2017) 0.75

Design Recommendations for Pharmacogenomics Clinical Decision Support Systems. AMIA Jt Summits Transl Sci Proc (2017) 0.75

Changing physicians' practices. N Engl J Med (1993) 7.12

Pharmacogenomics: "noninferiority" is sufficient for initial implementation. Clin Pharmacol Ther (2011) 2.43

Personalized medicine: building the GPS to take us there. Clin Pharmacol Ther (2007) 1.53

Company profile: Sequenom, Inc. Pharmacogenomics (2012) 1.44

Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet (1997) 13.93

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis (1998) 8.51

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA (2000) 8.31

Accurate inference of relationships in sib-pair linkage studies. Am J Hum Genet (1997) 7.78

Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology (1999) 7.32

Predicting the evolution of human influenza A. Science (1999) 6.91

Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature (1996) 6.72

A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03

Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol (1995) 5.86

Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci U S A (1997) 5.76

The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis (1999) 5.39

Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol (1990) 5.37

Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32

Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol (1999) 4.97

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis (1999) 4.67

Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis (1999) 4.59

Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature (1994) 4.28

The impact of influenza epidemics on hospitalizations. J Infect Dis (2000) 4.28

Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70

Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis (2000) 3.63

A randomised controlled trial comparing two schedules of antenatal visits: the antenatal care project. BMJ (1996) 3.50

Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J (2008) 3.36

The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34

A method for timely assessment of influenza-associated mortality in the United States. Epidemiology (1997) 3.31

Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J (2009) 3.05

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med (2001) 2.87

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet (2002) 2.85

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J (2002) 2.77

Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit? J Clin Oncol (1998) 2.69

Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet (1998) 2.66

Prediction of hypoxaemia at high altitude in children with cystic fibrosis. BMJ (1994) 2.64

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest (1998) 2.62

A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet (2000) 2.62

Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet (1998) 2.57

Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet (1995) 2.54

The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract (2004) 2.53

Neurophysiological correlates of age-related changes in human motor function. Neurology (2002) 2.52

Lung function in white children aged 4 to 19 years: I--Spirometry. Thorax (1993) 2.52

Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect (2001) 2.47

The importance of genealogy in determining genetic associations with complex traits. Am J Hum Genet (2001) 2.46

Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc Natl Acad Sci U S A (2000) 2.42

Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41

Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA (2000) 2.35

Methylation-specific PCR simplifies imprinting analysis. Nat Genet (1997) 2.33

Prevalence of scoliosis in cystic fibrosis. Pediatr Pulmonol (2012) 2.24

Evidence for different subgroups of difficult asthma in children. Thorax (2001) 2.22

Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr (2002) 2.20

The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys (1996) 2.15

Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J Clin Microbiol (1989) 2.09

Shortcomings of Acridine orange staining for malarial parasite. Indian J Med Microbiol (2007) 2.03

Mode-locked thulium-bismuth codoped fiber laser using graphene saturable absorber in ring cavity. Appl Opt (2013) 2.00

Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure ventilation. Circulation (1997) 1.99

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.99

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.99

Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J (2005) 1.98

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2001) 1.97

Reproducibility of random amplified polymorphic DNA (RAPD) analysis among laboratories. PCR Methods Appl (1993) 1.97

Membrane elasticity in giant vesicles with fluid phase coexistence. Biophys J (2005) 1.97

Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet (2000) 1.94

Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther (1999) 1.94

Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer. Clin Cancer Res (2000) 1.93

Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol (1993) 1.92

Recombination of human influenza A viruses in nature. Nature (1980) 1.92

Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology (2007) 1.90

Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin Pharmacol Ther (2007) 1.90

Flexible endoscopy of paediatric airways. Eur Respir J (2003) 1.90

Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses. Bull World Health Organ (1983) 1.89

Oral chemotherapy: rationale and future directions. J Clin Oncol (1998) 1.88

Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. J Toxicol Clin Toxicol (2001) 1.88

A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet (1998) 1.87

Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet (1998) 1.87

A study on habits of tobacco use among medical and non-medical students of Kolkata. Lung India (2011) 1.86

Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax (2004) 1.86

MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene (2011) 1.86

A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest (2000) 1.85

Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry (2012) 1.84

Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis (1995) 1.84

Rates of urinary tract injury from gynecologic surgery and the role of intraoperative cystoscopy. Obstet Gynecol (2006) 1.84

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine (1995) 1.83

Lesson of the week: right sided aortic arch in children with persistent respiratory symptoms. BMJ (2000) 1.81

Modification by diacylglycerol of the structure and interaction of various phospholipid bilayer membranes. Biochemistry (1986) 1.80

Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J Clin Microbiol (1995) 1.80

Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75

Airway function in infants newly diagnosed with cystic fibrosis. Lancet (2001) 1.72

Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res (1994) 1.72

Predicting hypoxaemia during flights in children with cystic fibrosis. Thorax (2001) 1.72

Effect of Sahaj Yoga on neuro-cognitive functions in patients suffering from major depression. Indian J Physiol Pharmacol (2007) 1.72

Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry (1997) 1.71

Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development? J Natl Cancer Inst (1999) 1.70

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol (1994) 1.65